rafik_tadros Profile Banner
Rafik Tadros Profile
Rafik Tadros

@rafik_tadros

Followers
544
Following
1K
Media
38
Statuses
885

Cardiologist-Electrophysiologist. Director, Cardiovascular Genetics Center @ICMtl. Canada Research Chair in cardiogenetics. Director of MD-research @UMontreal

Montreal, Canada
Joined July 2016
Don't wanna be here? Send us removal request.
@CirculationEP
CircEP
3 days
Mutations in the HCN4 gene may be the cause of incessant and inappropriate sinus tachycardia #AHAJournals #Epeeps https://t.co/XaKO7pBMnn
1
8
18
@iftikhar_kullo
Iftikhar J. Kullo
9 days
1/5 Pleased to share a review in @NatureRevGenet on Clinical Use of Polygenic Risk Scores: Current Status, Barriers & Future Directions Discusses PRSs in the context of the ACCE framework (analytic validity, clinical validity, clinical utility & ELSI) https://t.co/BK52kjAX4Q
1
7
20
@Ed_Alania
Edgardo Alania
3 months
💊 Flecainide for the Treatment of Andersen-Tawil Syndrome @JACCJournals #Cardiology #CardioEd #Epeeps #Genetics
2
15
52
@goupil_remi
Remi Goupil
3 months
Our new data on subclinical PA and MACE is out in Circulation! For the first time, we show that renin-independant aldosterone production is associated with an increased risk of MACE independently of BP, in people mostly normotensive with low CV risk. https://t.co/d1yBjfUQkY
Tweet card summary image
ahajournals.org
BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting...
2
13
47
@RobertAvramMD
Robert Avram
3 months
🔥 Our Nature paper just dropped! We built EchoNext—an AI model that reads ECGs to detect hidden structural heart disease (SHD) 💡 🔬 Trained on 1.2M ECG-echo pairs 🏥 Validated across 6 health systems 📈 AUROC 0.85 👀 Outperforms cardiologists 🚨 Finds undiagnosed SHD in 73%
@PierreEliasMD
Pierre Elias, MD
3 months
🧵1/Today, we published a key milestone towards AI based cardiac screening in Nature. https://t.co/Lr3ymIrgz5 EchoNext outperformed cardiologists and found thousands of high-risk patients missed in routine care. We also made a version available to the world.
2
4
21
@VDelgadoGarcia
Victoria Delgado
4 months
📢New Algorithm for Estimating LV Filling Pressure by Echo: 🔴increase in the number of patients in whom LV filling pressure can be estimated 🟢only 2 cases of indeterminate LV filling pressure and the majority had a definitive LV filling pattern https://t.co/4yL751yFFo
9
149
412
@CanadianSADS
The Canadian SADS Foundation
4 months
The TaRGET trial has opened up four new sites across Canada! There are now active sites in Montreal, Quebec City, Scarborough, and Victoria. To learn more about the trial and active sites, visit: https://t.co/JZJewRGE9Y #Cardiomyopathy #ACM #ARVC #ClinicalTrial
0
1
1
@goupil_remi
Remi Goupil
4 months
Aujourd’hui est un grand jour! Publication, pour la première fois, des lignes directrices d’Hypertension Canada en français! Merci à la Société québécoise d’hypertension artérielle pour le soutien à la traduction du guide et de ses annexes! https://t.co/fdpitrnZL0
Tweet card summary image
cmaj.ca
Contexte: Le Canada a longtemps figuré parmi les leaders mondiaux de la prise en charge de l’hypertension artérielle (HTA), mais ses taux de traitement et de maîtrise de l’HTA ont régressé ces...
0
1
7
@HeartsInRhythm
Hearts in Rhythm Organization
4 months
Gene-specific insights are transforming ARVC diagnosis, risk prediction & therapy. Precision medicine is here: https://t.co/my3AMMQOTx
0
2
3
@HeartsInRhythm
Hearts in Rhythm Organization
4 months
Detecting ARVC from ECG? A Canadian-led deep learning model shows high accuracy, paving the way for earlier diagnosis: https://t.co/siYU3McI5G
0
5
8
@GlobalHeartHub
Global Heart Hub
5 months
Cardiomyopathy symptoms can be subtle, like fatigue, dizziness or shortness of breath but knowing the signs and your family history could make all the difference. 🧬 It is often genetic. 🫀 It can lead to heart failure or sudden cardiac death if undiagnosed. 🗣️ If you feel
0
9
14
@JACCJournals
JACC Journals
5 months
In this #JACCBTS review, Dr. @JolandavanderV4, et al provide an overview of genetic #cvHCM models, including main HCM hallmarks such as impaired relaxation, hypertrophy, fibrosis, myocardial or sarcomere disarray, & ventricular/cellular arrhythmias https://t.co/oLkOZJqV1z
0
2
8
@AJHGNews
AJHG
5 months
📣New from Nicastro et al! 📄Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic #cardiomyopathy https://t.co/aKppPsbQkj
0
5
9
@RigsHeart
RigsHeart 🫀🚨
5 months
Just out 📢 in @AJHGNews 🧬 Bi-allelic variants in POPDC2 identified in 4 families with sinus node dysfunction, AV conduction defects, and hypertrophic cardiomyopathy. 🫀Mechanism? Impaired cAMP-dependent regulation of TREK-1 potassium channels, disrupting cardiac pacemaking &
0
5
9
@rafik_tadros
Rafik Tadros
5 months
0
0
2
@rafik_tadros
Rafik Tadros
5 months
Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathy - ScienceDirect
1
3
9
@victor_waldmann
Victor Waldmann
5 months
🚨 Very happy to share our last article just published in @ESC_Journals 🇨🇵 Nationwide prospective data on catheter ablations ⚡ in patients with congenital heart disease 🫀 A huge thank to all investigators! https://t.co/QayHnBCI4g @APHP #EPeeps
Tweet card summary image
academic.oup.com
AbstractBackground and Aims. Current evidence on catheter ablation for patients with congenital heart disease (CHD) is derived from small, retrospective st
1
4
5
@guichard_jb
JB Guichard_EP
5 months
Can Heart Rate Fragmentation predict AF in the general population aged 65+? 🔍 Risk stratification based on Heart Rate Variability enables smarter AF screening. 📷 https://t.co/3Ab6yYYJyr @DrFuSiongNg @ivroca @aportasanchez @LluisMont2 #AFib #EPeeps #CardioTwitter
Tweet card summary image
academic.oup.com
AbstractAims. Screening the general population aged 65 for atrial fibrillation (AF) has been proposed as a preventive measure against potential complicatio
2
3
10